Osaic Holdings’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Osaic Holdings’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40	Closed	-$210	–	7507
2023 Q3	$210	Buy	40 +16	+67%	+$99	﹤0.01%	7146
2023 Q2	$169	Buy	24 +14	+140%	+$121	﹤0.01%	7233
2023 Q1	$95	Hold	10	–	–	﹤0.01%	7337
2022 Q4	$0	Buy	10 +4	+67%	+$50	﹤0.01%	7499
2022 Q3	$0	Buy	+6	New	+$176	﹤0.01%	7578

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings's NEXI Position: Q4 2023 in Review

Osaic Holdings sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 40 shares — an estimated $210 sold.

Osaic Holdings first reported a position in NEXI in Q3 2022 and held it in 5 quarters. The position peaked at $210 in Q3 2023. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Osaic Holdings reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 40 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $210.
Osaic Holdings first reported a position in NexImmune, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Osaic Holdings's NexImmune, Inc. Common Stock position peaked at $210 in Q3 2023.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.